Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07274683Not yet recruiting
Open-label, single-arm trial of ropivacaine in Prolonged Disorders of Consciousness (PDOC), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change in total sleep time. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07274683.